Advertisement
Merck & Co., Inc.

Merck & Co., Inc. (MRK) Stock Overview

Explore Merck & Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.

MRKNYSE
HealthcareDrug Manufacturers - General
$119.09
$0.51(0.43%)
U.S. Market opens in 14h 59m
Advertisement

Merck & Co., Inc. (MRK)

Meyka AI Score

Z

Key Financials

Market Cap294.1B
P/E Ratio32.85
EPS (TTM)$3.55
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$108.17
3 Months$108.54
1 Year Target$136.48

MRK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Merck & Co., Inc. (MRK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $136.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.85 and a market capitalization of 294.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.43%
5-Day Change
-1.53%
1-Month Change
6.92%
3-Month Change
1.71%
6-Month Change
21.99%
Year-to-Date (YTD) Change
13.14%
1-Year Change
46.39%
3-Year Change
8.40%
5-Year Change
56.41%
All-Time (Max) Change
30021.15%

Contact Information

908 740 4000
126 East Lincoln Avenue, Rahway, NJ, 07065

Company Facts

73,000 Employees
IPO DateJan 13, 1978
CountryUS
Actively Trading

Frequently Asked Questions